Table 2 Baseline and post-intervention scores, and results of the independent samples t test for pre/post-intervention differences (Δ) between study groups.
Control Group (n = 10) | Experimental Group (n = 8) | Δ (T1-T2) | Test statistics | ||||||
|---|---|---|---|---|---|---|---|---|---|
Baseline M (SD) | Post-intervention M (SD) | Baseline M (SD) | Post-intervention M (SD) | ΔCG M (SD) | ΔEG M (SD) | t (df) | p | d | |
No. missed work days (last month)a | 0 | 0.83 (2.04) | 7.00 (13.04) | 1.2 (1.79) | −0.833 (2.04) | 5.80 (13.57) | −1.083 (4) | 0.338 | −0.656 |
No. bleeds last month | 0.90 (1.91) | 1.20 (1.40) | 1.25 (1.17) | 1.50 (1.69) | −0.30 (1.42) | −0.25 (1.83) | −0.065 (16) | 0.949 | −0.031 |
Pain intensity | 4.27 (1.77) | 3.81 (1.51) | 4.22 (1.99) | 4.13 (1.09) | 0.46 (2.11) | 0.09 (1.48) | 0.412 (16) | 0.686 | 0.195 |
Pain interference | 3.05 (1.58) | 2.64 (1.72) | 3.96 (2.62) | 3.21 (2.30) | 0.41 (0.99) | 0.75 (1.53) | −0.563 (16) | 0.581 | −0.267 |
EQ-5D-5L: VAS | 62.5 (13.99) | 55.00 (13.33) | 56.25 (21.17) | 70.00 (18.89) | 7.50 (17.20) | −13.75 (10.94) | 3.029 (16) | 0.008 | 1.437 |
EQ-5D-5L: Index score | 0.70 (0.08) | 0.74 (0.08) | 0.58 (0.23) | 0.68 (0.09) | −0.04 (0.12) | −0.09 (1.48) | 0.703 (16) | 0.492 | 0.334 |
A36 Hemofilia-QoL: global score | 99.7 (13.06) | 108.9 (13.83) | 92.38 (28.25) | 107.13 (23.27) | −9.20 (8.87) | −14.75 (20.78) | 0.706 (9) | 0.498 | 0.335 |
Physical health [0–32] | 19.90 (2.52) | 21.80 (4.29) | 18.75 (6.88) | 22.38 (4.63) | −1.90 (5.20) | −3.63 (6.55) | 0.624 (16) | 0.541 | 0.296 |
Daily activities [0–16] | 10.00 (3.59) | 12.40 (3.63) | 7.38 (6.23) | 12.38 (4.07) | −2.40 (3.47) | −5.00 (5.50) | 1.225 (16) | 0.238 | 0.581 |
Joints [0–12] | 7.50 (2.17) | 6.90 (1.85) | 6.88 (1.73) | 7.00 (3.16) | 0.60 (2.32) | −0.13 (2.59) | 0.626 (16) | 0.540 | 0.297 |
Pain [0–8] | 4.30 (2.11) | 5.20 (1.40) | 4.50 (1.07) | 5.13 (1.36) | −0.90 (2.28) | −0.63 (2.07) | −0.265 (16) | 0.795 | −0.126 |
Treatment satisfaction [0–8] | 6.40 (1.58) | 6.60 (1.08) | 6.88 (1.13) | 6.75 (0.89) | −0.20 (1.23) | 0.13 (0.99) | −0.606 (16) | 0.553 | −0.288 |
Treatment difficulties [0–16] | 14.60 (1.58) | 13.70 (3.16) | 11.28 (3.85) | 12.75 (2.38) | 0.90 (2.88) | −1.50 (2.73) | 1.797 (16) | 0.091 | 0.852 |
Emotional functioning [0–20] | 12.20 (3.55) | 15.90 (2.89) | 13.13 (4.91) | 15.50 (3.21) | −3.70 (2.95) | −2.38 (4.34) | −0.771 (16) | 0.452 | −0.366 |
Mental health [0–12] | 8.50 (2.55) | 9.20 (2.20) | 8.00 (3.21) | 8.50 (3.78) | −0.70 (3.83) | −0.50 (1.60) | −0.138 (16) | 0.892 | −0.066 |
Relationships and social activity [0–20] | 16.30 (2.91) | 17.20 (1.62) | 15.63 (5.29) | 16.75 (6.32) | −0.90 (2.77) | −1.13 (3.27) | 0.158 (16) | 0.876 | 0.075 |
HADS: Depression | 0.60 (1.07) | 0.50 (0.71) | 1.50 (3.85) | 1.50 (3.85) | 0.10 (1.29) | 0 (0.53) | 0.205 (16) | 0.840 | 0.097 |
HADS: Anxiety | 3.50 (2.88) | 3.60 (2.55) | 3.38 (2.56) | 3.50 (3.16) | −0.10 (2.99) | −0.13 (2.42) | 0.019 (16) | 0.985 | 0.009 |
